건강인 대상의 유전자검사에 대한 이해와 관련 국내 제도

키워드

참고문헌 (31)

1. Stark Z, "Integrating genomics into healthcare : a global responsibility", Am J Hum Genet, 104, pp.13~20 (2019)
2. All of Us Research Program Genomics Investigators, "Genomic data in the All of Us Research Program", Nature, 627, pp.340~346 (2024)
3. Smedley D, "100, 000 genomes pilot on rare-disease diagnosis in health care-preliminary report", N Engl J Med, 385, pp.1868~1880 (2021)
4. Allyse MA, "Direct-to-consumer testing 2. 0 : emerging models of direct-to-consumer genetic testing", Mayo Clin Proc, 93, pp.113~120 (2018)
5. Kalokairinou L, "Legislation of direct-to-consumer genetic testing in Europe : a fragmented regulatory landscape", J Community Genet, 9, pp.117~132 (2018)
6. Milo Rasouly H, "Cases in precision medicine : genetic testing to predict future risk for disease in a healthy patient", Ann Intern Med, 174, pp.540~547 (2021)
7. Park KS, "Neurogenetics for the practitioner", pp.51~63 (2024), Academic Press, an imprint of Elsevier
8. Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
9. Kim SW, "Re-evaluation of a fibrillin-1 gene variant of uncertain significance using the ClinGen guidelines", Ann Lab Med, 44, pp.271~278 (2024)
10. Park KS, "A population-based analysis of BRCA1", 2 genes and associated breast and ovarian cancer risk in Korean patients : a multicenter cohort study, 2021, pp.13, 2192~
11. Walsh N, "Variant reclassification and clinical implications", J Med Genet, 61, pp.207~211 (2024)
12. Tam V, "Benefits and limitations of genome-wide association studies", Nat Rev Genet, 20, pp.467~484 (2019)
13. Maxwell KN, "Toward application of polygenic risk scores to both enhance and deintensify breast cancer screening", J Clin Oncol, 42, pp.1462~1465 (2024)
14. Cano-Gamez E, "From GWAS to function : using functional genomics to identify the mechanisms underlying complex diseases", Front Genet, 11, pp.424~ (2020)
15. Duncan L, "Analysis of polygenic risk score usage and performance in diverse human populations", Nat Commun, 10, pp.3328~ (2019)
16. Peterson RE, "Genome-wide association studies in ancestrally diverse populations : opportunities, methods, pitfalls, and recommendations", Cell, 179, pp.589~603 (2019)
17. Martin AR, "Clinical use of current polygenic risk scores may exacerbate health disparities", Nat Genet, 51, pp.584~591 (2019)
18. Foo JN, "Identification of risk loci for Parkinson disease in Asians and comparison of risk between Asians and Europeans : a genome-wide association study", JAMA Neurol, 77, pp.746~754 (2020)
19. Giannakopoulou O, "The genetic architecture of depression in individuals of East Asian ancestry : a genome-wide association study", JAMA Psychiatry, 78, pp.1258~1269 (2021)
20. Lu Y, "Large-scale genome-wide association study of East Asians identifies loci associated with risk for colorectal cancer", Gastroenterology, 156, pp.1455~1466 (2019)
21. Kim MS, "Genetic disease risks can be misestimated across global populations", Genome Biol, 19, pp.179~ (2018)
22. Choi SW, "Tutorial : a guide to performing polygenic risk score analyses", Nat Protoc, 15, pp.2759~2772 (2020)
23. Lewis CM, "Polygenic risk scores : from research tools to clinical instruments", Genome Med, 12, pp.44~ (2020)
24. Sud A, "Will polygenic risk scores for cancer ever be clinically useful?", NPJ Precis Oncol, 5, pp.40~ (2021)
25. Uffelmann E, "Genome-wide association studies of polygenic risk score-derived phenotypes may lead to inflated false positive rates", Sci Rep, 13, pp.4219~ (2023)
26. Tandy-Connor S, "False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care", Genet Med, 20, pp.1515~1521 (2018)
27. Mars N, "Comprehensive inherited risk estimation for risk-based breast cancer screening in women", J Clin Oncol, 42, pp.1477~1487 (2024)
28. Mavaddat N, "Polygenic risk scores for prediction of breast cancer and breast cancer subtypes", Am J Hum Genet, 104, pp.21~34 (2019)
29. Lee A, "BOADICEA : a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors", Genet Med, 21, pp.1708~1718 (2019)
30. Miller DT, "ACMG SF v3. 2 list for reporting of secondary findings in clinical exome and genome sequencing : a policy statement of the American College of Medical Genetics and Genomics(ACMG)", Genet Med, 25, pp.100866~ (2023)
31. Kim Y, "Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study", Hum Genet, 142, pp.1561~1569 (2023)

관련 논문AI추천